| Pfizer AG - Comirnaty® 10 Mikrogramm/Dosis, Konzentrat zur Herstellung einer Injektionsdispersion | | 68710 | | 02 | | Comirnaty® 10 Mikrogramm/Dosis | | Konzentrat zur Herstellung einer Injektionsdispersion | | J07BN01 | | covid-19, RNA-based vaccine | | 10.12.2021 | | |
| | Composition | | Suspension: tozinameranum 0.1 mg/ml, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas), 2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, saccharum, trometamolum, trometamoli hydrochloridum, aqua ad iniectabile, 1 ml corresp.. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
